Table 4.

Patents related to parenteral nanosuspension.

No.	Title	Area of invention/final product description	Advantages/applications/claims	Refs.
1	An aqueous suspension of submicron 9-hydroxyrisperidone fatty acid esters	A pharmaceutical composition suitable as a depot formulation for administration via IM or SC route	Administration by IM or SC injection provides therapeutically effective formulation by improving bioavailability	42
2	Pharmaceutical nanosuspension for medicament administration as systems with increased saturation solubility and rate of solution	Preparation of nanosuspension formulation	Nanosuspension formulation provides good bioavailability by increasing the saturation solubility and dissolution rate compared with powders of active compounds	136
3	Nano-particulate formulation of fenofibrate	Nanosuspension prepared using vitamin E TPGS as a stabilizer	Stable fenofibrate nano-particulate (nanosuspension) with vitamin E-TPGS without the addition of any stabilizer	137
4	Parenteral and oral formulations of benzimidazole	Parenteral and oral nanosuspension	Benzimidazole nanosuspension formulation for oral and parenteral delivery, which provides a better effect on oral bioavailability and good therapeutic efficacy	115
5	Novel compositions	The final product as nanosuspension for parenteral administration	Spironolactone nanosuspension preparation for solubility enhancement and improving bioavailability by increasing saturation solubility	137